Überhöhte interne Kosten für manuelle Bearbeitung von Beschwerden und MDR‑Bewertungen
Definition
ARGMD and TGA’s regulatory framework require sponsors and manufacturers to maintain robust post‑market monitoring, including risk assessment and investigation of medical device adverse event and complaint reports and maintaining technical documentation.[5][4] Typical complaint-handling processes have multiple phases—intake, investigation, and closure—each requiring data capture, assessment of reportability, and potentially preparation of vigilance reports or recall documentation.[2][4] When these steps are executed with manual tools (email, spreadsheets, disconnected databases), RA/QA specialists often spend several hours per complaint on information gathering, classification, and documentation to meet TGA expectations, including traceability to risk management files and CAPA where necessary.[2][5] Assuming a blended RA/QA labour cost of AUD 80–120 per hour in Australia, and 10–15 hours of effort for complex or potentially reportable complaints (intake clarification, investigation coordination, MDR assessment, documentation, and management review), the internal cost per escalated complaint easily reaches AUD 800–1,800. For a mid‑size manufacturer handling 150–300 such complaints annually, this results in AUD 120,000–540,000 in internal overhead, a significant portion of which is avoidable with workflow automation, integrated data capture, and MDR decision support (logic extrapolated from standard labour costing applied to the complaint workflow described in industry guidance).
Key Findings
- Financial Impact: Logic-based estimate: AUD 800–1,800 internal labour cost per escalated or potentially reportable complaint; equating to roughly AUD 120,000–540,000 annually for 150–300 such complaints at a mid‑size manufacturer.
- Frequency: High frequency for all complaints and adverse events; recurring monthly and scaling with installed base size.
- Root Cause: Manual, non‑integrated complaint intake; lack of structured forms aligned with TGA/ARGMD data requirements; duplication of data entry between CRM, QMS, and vigilance systems; absence of automated MDR decision trees and templates.
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Medical Equipment Manufacturing.
Affected Stakeholders
Quality Assurance Specialist, Regulatory Affairs Specialist, Post‑Market Surveillance Manager, Customer Service/Technical Support, Head of Quality
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.